PBA
Paradigm Biocapital Advisors Portfolio holdings
AUM
$2.34B
This Quarter Return
-1.92%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$2.61B
AUM Growth
-$228M
(-8%)
Cap. Flow
-$35.8M
Cap. Flow
% of AUM
-1.37%
Top 10 Holdings %
Top 10 Hldgs %
64.57%
Holding
44
New
10
Increased
10
Reduced
11
Closed
9
Top Buys
| 1 |
Merus
MRUS
|
$120M |
| 2 |
Revolution Medicines
RVMD
|
$91M |
| 3 |
Janux Therapeutics
JANX
|
$65.5M |
| 4 |
Cogent Biosciences
COGT
|
$30.6M |
| 5 |
Nuvalent
NUVL
|
$29.9M |
Top Sells
| 1 |
Immunocore
IMCR
|
$116M |
| 2 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$84.1M |
| 3 |
BCYC
Bicycle Therapeutics
BCYC
|
$80.8M |
| 4 |
Vaxcyte
PCVX
|
$46.3M |
| 5 |
AUTL
Autolus Therapeutics
AUTL
|
$41M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cullinan Oncology
CGEM
$449M
| $26.9M | 1.03% |
1,542,805
+194,790
| +14% | +$3.4M |
|
27
Erasca
ERAS
$400M
| $17.1M | 0.65% |
+7,250,000
| New | +$17.1M |
|
|
CMPS
28
Compass Pathways
CMPS
$458M
| $14.1M | 0.54% |
2,335,926
-55,062
| -2% | -$333K |
|
29
Apogee Therapeutics
APGE
$2.27B
| $13M | 0.5% |
330,000
| – | – |
|
|
VRNA
30
Verona Pharma
VRNA
$9.18B
| $10.4M | 0.4% |
+721,087
| New | +$10.4M |
|
31
ALX Oncology
ALXO
$54.1M
| $9.5M | 0.36% |
+1,575,605
| New | +$9.5M |
|
32
Perspective Therapeutics
CATX
$244M
| $9.17M | 0.35% |
+919,692
| New | +$9.17M |
|
33
Vor Biopharma
VOR
$253M
| $6.46M | 0.25% |
6,457,293
| – | – |
|
34
Acrivon Therapeutics
ACRV
$41.8M
| $3.83M | 0.15% |
+659,724
| New | +$3.83M |
|
35
TScan Therapeutics
TCRX
$106M
| $2.07M | 0.08% |
+353,886
| New | +$2.07M |
|
36
Agios Pharmaceuticals
AGIO
$2.08B
| – | – |
-400,000
| Closed | -$11.7M |
|
|
AUTL
37
Autolus Therapeutics
AUTL
$383M
| – | – |
-6,425,803
| Closed | -$41M |
|
|
BCYC
38
Bicycle Therapeutics
BCYC
$489M
| – | – |
-3,246,759
| Closed | -$80.8M |
|
39
Caribou Biosciences
CRBU
$174M
| – | – |
-2,172,620
| Closed | -$11.2M |
|
|
CRGX
40
DELISTED
CARGO Therapeutics
CRGX
| – | – |
-147,959
| Closed | -$3.3M |
|
|
41
Immunocore
IMCR
$1.75B
| – | – |
-1,787,176
| Closed | -$116M |
|
42
Zentalis Pharmaceuticals
ZNTL
$123M
| – | – |
-944,917
| Closed | -$14.9M |
|
43
Kyverna Therapeutics
KYTX
$161M
| – | – |
-50,000
| Closed | -$1.24M |
|
|
ALPN
44
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – |
-2,121,163
| Closed | -$84.1M |
|